News

  • Jan 2024

    William G. Rohrer Charitable Foundation Awards Coriell $500,000 for Cancer Biobank

    The William G. Rohrer Charitable Foundation has awarded the Coriell Institute for Medical Research $500,000 to develop the Coriell-Cooper Cancer Biobank, a new collection of biological samples derived from people undergoing treatment for cancer.

    read more

  • Jan 2024

    Coriell Names Denise Buscher New Chief Financial Officer

    The Coriell Institute for Medical Research announces the promotion of Denise Buscher, a longtime member of the Coriell team, as its new Chief Financial Officer.

    read more

  • Nov 2023

    Fentanyl Found in Nearly All Overdose Deaths Analyzed by CORI

    Scientists from the Camden Opioid Research Initiative analyzed the toxicology findings from dozens of people who died from opioid overdoses and their findings were published this week in PLOS ONE.

    read more

  • Oct 2023

    New iPSC Lines Added to NHGRI Repository

    New induced pluripotent stem cell (iPSC) lines have been added to the National Human Genome Research Institute’s Sample Repository for Human Genetic Research (NHGRI Repository). These two iPSC lines are the first of their kind to be introduced to the collection.

    read more

  • Sep 2023

    Coriell Welcomes Two Faculty Members to Research Team

    The Coriell Institute for Medical Research is proud to announce the addition of two scientists to its research team: Shumei Song, MD, PhD, and Nora I. Engel, PhD. Dr. Song and Dr. Engel will each lead labs at Coriell and their work will contribute to and benefit from the newly formed Camden Cancer Research Center (or CCRC), a three-way partnership between Coriell, Cooper University Health Care, and Cooper Medical School of Rowan University to study cancer biology and develop new therapies.

    read more

  • Jul 2023

    Camden Institutions Partner to Launch Groundbreaking Camden Cancer Research Center

    In a significant collaborative effort, the Coriell Institute for Medical Research, Cooper University Health Care, and Cooper Medical School of Rowan University (CMSRU) have launched the Camden Cancer Research Center (CCRC), a partnership to investigate cancer and translate basic cancer science into new treatments. The three organizations have pledged an initial $30 million to start this center.

    read more

  • Jun 2023

    GWAS Study Bolsters Links Between Genome and Caffeine Consumption

    New research from the Coriell Institute for Medical Research bolsters the links between one’s genetics and caffeine consumption and identifies areas of the genome where genetic variations may cause variations in consumption. Titled “Genome-wide Association Study of Caffeine Consumption Using Coriell Personalized Medicine Collaborative Data,” the article detailing these results was published last month in Genetics & Molecular Medicine.

    read more

  • Jan 2023

    Samples from Nonhuman Primates Now Available from NIA’s Aging Cell Repository

    Biological samples from nonhuman primates are now available from the National Institute on Aging (NIA) Aging Cell Repository. The collection of nonhuman primate biomaterials available for distribution has recently been expanded to include 27 unique species, up from 10 previously. Several species have a broad representation of sex and age.

    read more

  • Jan 2023

    Coriell Welcomes Xiaoxin Luke Chen, MD, PhD, to its Research Team

    Recent work from Dr. Chen’s lab has focused on metabolism and cell signaling with regard to esophageal squamous cell carcinoma, a type of cancer that forms in the lining of the esophagus. His team has published numerous papers in leading journals, including the Journal of Pathology, Nature, and Cell Stem Cell.

    read more

  • Sep 2022

    Coriell Scientists Awarded Grants to Study Cancer Epigenetics, Improve Therapies

    The New Jersey Commission on Cancer Research has awarded two Coriell scientists a pair of grants to support research into the epigenetic underpinnings of cancer and how this knowledge can be used to improve treatments. These grants, each for $400,000, will support two research programs for two years.

    read more